# OnCo record paper-destiny-lung02-goto-jco-2023 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-destiny-lung02-goto-jco-2023/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-destiny-lung02-goto-jco-2023" ;
  schema:name "DESTINY-Lung02: two doses of trastuzumab deruxtecan in HER2-mutant metastatic non-small-cell lung cancer"@en ;
  schema:description "Comparing two doses of trastuzumab deruxtecan in HER2-mutant lung cancer showed that the lower 5.4 mg/kg dose gave the same response rate of about half with far less lung toxicity, fixing the approved dose."@en ;
  schema:url <https://onco.cc/key-papers/paper-destiny-lung02-goto-jco-2023/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.23.01361>, <https://pubmed.ncbi.nlm.nih.gov/37694347/> ;
  schema:sameAs <https://doi.org/10.1200/JCO.23.01361> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "Goto K, Goto Y, Kubo T, et al." ;
  onco:cancers <https://onco.cc/cancers/her2-mutant-nsclc/> ;
  onco:drugs <https://onco.cc/drugs/trastuzumab/>, <https://onco.cc/drugs/trastuzumab-deruxtecan/> ;
  onco:trials <https://onco.cc/trials/destiny-lung02/> ;
  onco:journals <https://onco.cc/journals/jco/> .
